PROGNOSTIC FACTORS AND SURVIVAL IN TRIPLE NEGATIVE AND NON-TRIPLE NEGATIVE BREAST CANCER: EXPERIENCE OF A TERTIARY CARE CANCER CENTER IN ODISHA.

Authors

  • Prasant Kumar Parida Department of Medical Oncology, Acharya Harihar Postgraduate Institute of Cancer, Cuttack.
  • Subrat Kumar Samantara Department of Surgical Oncology, Acharya Harihar Postgraduate Institute of Cancer, Cuttack.
  • Sashibhusan Dash Department of Oncopathology, Acharya Harihar Postgraduate Institute of Cancer, Cuttack.

DOI:

https://doi.org/10.32553/ijmbs.v5i11.2310

Keywords:

Breast cancer; survival; triple-negative breast cancer.

Abstract

Background: Because of its high-risk biological features and lack of effective treatment options, triple-negative breast cancer (TNBC) has received greater clinical and experimental interest.

Aim and objectives: The aim of this study was to compare and analyze the clinicopathological features, recurrence, metastasis, and prognosis of patients with TNBC and non-triple negative breast cancer (non-TNBC).

Material and methods: This single hospital-based retrospective study was conducted on patients who were histopathologically diagnosed with breast cancer and subsequently treated from 2017 to 2018 at the Acharya Harihar Postgraduate Institute of Cancer. The clinical features and prognosis of TNBC and non-TNBC were compared.

Results: This study comprised a total of 111 patients, with 36 (32.43%) being TNBC and 75 (67.56%) being non-TNBC. TNBC has 22 patients under the age of 40 (61.1%). Grade III tumors were seen in 47% of TNBC patients and 21% of non-TNBC patients (p-value = 0.05). The disease free survival (DFS) was determined to be 58 % for TNBC and 82% for non-TNBC groups, respectively (p-value = 0.05). These two groups had an overall survival rate (OS) of 72% and 92%, respectively (p-value = 0.05).

Conclusion: When compared to non-TNBC, TNBC was related to high-grade malignancies, worse disease-free survival , and overall survival (OS) rates. Understanding the molecular features of TNBC, clarifying its mechanism at the molecular level, interpreting the gene expression profiles of TNBC, and studying and creating new therapeutic targets should be the focus of future research. To enhance the prognosis of TNBC patients, try to find a focused and effective therapy.

Keywords: Breast cancer; survival; triple-negative breast cancer.

Downloads

Published

2021-11-23

How to Cite

Parida , P. K. ., Samantara, S. K. ., & Dash , S. . (2021). PROGNOSTIC FACTORS AND SURVIVAL IN TRIPLE NEGATIVE AND NON-TRIPLE NEGATIVE BREAST CANCER: EXPERIENCE OF A TERTIARY CARE CANCER CENTER IN ODISHA. International Journal of Medical and Biomedical Studies, 5(11). https://doi.org/10.32553/ijmbs.v5i11.2310

Issue

Section

Articles